The First Approved Agent in the Glitazar’s Class: Saroglitazar

E-ISSN： 1873-5592|15|2|151-155

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.2, 2014-02, pp. : 151-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Caspofungin: first approved agent in a new class of antifungals

By Johnson Melissa D Perfect John R

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 807-823

Informa Healthcare

Access to resources Recommend Favorite

Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 8, 2005-07 ,pp. : 1421-1423

Informa Healthcare

Access to resources Recommend Favorite

Update on daptomycin: the first approved lipopeptide antibiotic

By Lee Su Young Fan Hong Wei Kuti Joseph L Nicolau David P

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 10, 2006-07 ,pp. : 1381-1397

Informa Healthcare

Access to resources Recommend Favorite

Rituximab The First Monoclonal Antibody Approved for the Treatment of Lymphoma

Current Pharmaceutical Biotechnology, Vol. 1, Iss. 1, 2000-01 ,pp. : 1-9

Bentham Science Publishers

Access to resources Recommend Favorite

Eprodisate first in class for AA amyloidosis

Inpharma, Vol. 1, Iss. 1545, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite